Form 4 holding
Director
Ambrx Biopharma Inc.
- Security class
- Ordinary Shares
- Shares / value
- 85,000
- Estimated value
- $785,800
- Report date
- 07 Jun 2023
- Price
- $9.24
- Ownership
- Direct
Stephen C. Glover - Director at Ambrx Biopharma Cayman, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- AMAM
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Stephen C. Glover since 21 Sep 2025
Reported holdings for Stephen C. Glover in Ambrx Biopharma Cayman, Inc.
Form 4 holding
Director
Ambrx Biopharma Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 17,500
- Estimated value
- Report date
- 18 May 2023
- Price
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
Transaction history for Stephen C. Glover in Ambrx Biopharma Cayman, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.